WS
CVS icon

Wela Strategies’s CVS Health CVS Stock Holding History

Wela Strategies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,567
Closed -$539K – 59
2024
Q3 		$539K Buy
8,567
+2,193
+34% +$128K 0.23% 29
2024
Q2 		$376K Buy
6,374
+134
+2% +$8.38K 0.18% 44
2024
Q1 		$498K Sell
6,240
-341
-5% -$26K 0.24% 31
2023
Q4 		$520K Buy
6,581
+746
+13% +$53.1K 0.28% 29
2023
Q3 		$407K Buy
5,835
+1,438
+33% +$102K 0.24% 33
2023
Q2 		$304K Buy
4,397
+30
+0.7% +$2.13K 0.23% 36
2023
Q1 		$325K Buy
+4,367
New +$366K 0.17% 40

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wela Strategies's CVS Position: Q4 2024 in Review

Wela Strategies sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,567 shares — an estimated $539K sold.

Wela Strategies first reported a position in CVS in Q1 2023 and held it in 7 quarters. The position peaked at $539K in Q3 2024. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Wela Strategies reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Wela Strategies sold 8,567 CVS Health shares in Q4 2024, an estimated $539K.
  • Wela Strategies first reported a position in CVS Health in Q1 2023 and held it in 7 quarters.
  • Wela Strategies's CVS Health position peaked at $539K in Q3 2024.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Wela Strategies's 13F filing for Q4 2024, filed 13 Jan 2025.